Heerlen, NL, 12 Jun 2020 08:15 CEST
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has completed the repurchase of 1.4 million of its own shares at an average price of €98.40. This repurchase covers commitments under share-based compensation plans and shares for stock dividend, in accordance with the announcement on March 2, 2020. The consideration of this repurchase was €137.8 million.
In addition, as a prudent measure given the current Covid-19 environment and given the acquisition of Erber Group announced today, DSM has decided to cancel the remainder of its €1 billion share buy-back program. The €1 billion share buy-back program was first announced on February 14, 2019, with the intention to reduce DSM’s issued share capital. Under this program, DSM repurchased 5.4 million shares for a total consideration of €600 million in 2019 and DSM repurchased another 1.3 million shares for a total consideration of €145 million in 2020, bringing the total number of shares repurchased to around 6.6 million shares for a total consideration of €745 million.
These Daily Transaction Details Share Repurchase Program spreadsheets were updated weekly during the course of the buy-back program:
Senior Communications Manager
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864